$447 Million is the total value of SECTOR GAMMA AS's 37 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ITCI | INTRA-CELLULAR THERAPIES INC | $4,615,000 | -6.7% | 80,843 | 0.0% | 1.03% | -3.9% | |
| SAGE | SAGE THERAPEUTICS INC | $3,827,000 | -2.4% | 118,476 | 0.0% | 0.86% | +0.5% | |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | $2,758,000 | -17.8% | 46,221 | 0.0% | 0.62% | -15.4% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $1,657,000 | -62.2% | 1,466,678 | 0.0% | 0.37% | -61.1% | |
| QTRX | QUANTERIX CORP | $1,436,000 | -44.5% | 88,670 | 0.0% | 0.32% | -42.9% | |
| SOMALOGIC INC | $1,362,000 | -43.6% | 301,224 | 0.0% | 0.30% | -41.9% | ||
| ATRA | ATARA BIOTHERAPEUTICS INC | $964,000 | -16.1% | 123,713 | 0.0% | 0.22% | -13.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-05
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.